Fulcrum Therapeutics, Inc.

FULC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Apr 28, 2023 DEFA14A
DEF 14A Apr 28, 2023 DEF 14A
PRE 14A Apr 18, 2023 PRE 14A
8-K Apr 5, 2023 8-K
S-8 Mar 9, 2023 S-8
10-K Mar 9, 2023 10-K
8-K Mar 9, 2023 8-K
SC 13G Mar 6, 2023 FULCRUM THERAPEUTICS, INC.
SC 13G/A Feb 14, 2023 SCHEDULE 13G/A, AMENDMENT #1
SC 13G/A Feb 14, 2023 SC 13G/A
SC 13G/A Feb 14, 2023 FULCRUM THERAPEUTICS, INC.
4 Feb 13, 2023 FORM 4 SUBMISSION
4 Feb 13, 2023 FORM 4 SUBMISSION
4 Feb 13, 2023 FORM 4 SUBMISSION
4 Feb 13, 2023 FORM 4 SUBMISSION
SC 13G/A Feb 13, 2023
SC 13G/A Feb 9, 2023 FULCRUM THERAPEUTICS, INC.
SC 13G/A Feb 9, 2023
SC 13G/A Feb 1, 2023
4 Jan 24, 2023 OWNERSHIP DOCUMENT
SC 13G/A Jan 23, 2023 COWEN FINANCIAL PRODUCTS LLC
8-K Jan 18, 2023 8-K
424B5 Jan 18, 2023 424B5
424B5 Jan 17, 2023 424B5
8-K Jan 17, 2023 8-K
← Newer Page 9 of 21 · 513 filings Older →